Notable Analyst Rating Changes 4/2: VOD, CHL, AZN Upgraded; UST, CROX, DKS Downgraded
More News related to AZN
- Arnold & Itkin Announces Lawsuits Over Defective Pain Pumps
- Actress Debi Mazar Talks About her Family's Experience with Bipolar Depression
- Notable Analyst Rating Changes 11/09: RSH, ANF, NOC, ADBE, HERO Upgraded; RIMM, RHT, GPS, AZN, SGY Downgraded
- RBS Upgrades AstraZeneca (AZN) to Buy
- J.P. Morgan Downgrades AstraZeneca (AZN) to Underweight
More News related to CHL
- Morgan Stanley Upgrades CHU to Overweight, Downgrades CHL, CHA to Equal Weight
- China Mobile Selects mInfo as SNS Mobile Search and Ad Partner
- IRG Technology, Media and Telecoms Weekly China Market Review
- Highlights From SINA's Q2 Conference Call: Despite Strong Pick-up in Q2, Visibility is Still Low
- Davenport Downgrades China Mobile Limited (CHL) to Sell; Raises Risk Rating to Above Average
More News related to CROX
- Standpoint Research Downgraded Deckers Outdoor (DECK) to Hold
- Standpoint Research Initiates Coverage on Crocs (CROX) with a Buy
- Unusual 11 Mid-Day Movers 11/06: CBBO, OPTT, GROW, MGA Higher; GOK, OSTE, NHWK, OCLS Lower
- Morning Movers 11/06: ACLS, CVM, ZIOP, LPSN, CABL, ZGEN Higher; NHWK, GOK, CROX, CVI, RAIL, CSTR Lower
- Piper Jaffray Maintains an 'Overweight' Rating on Crocs (CROX); Channel Diversity Providing Topline Hedge
More News related to Special Reports
- Unusual 11 Mid-Day Movers 11/11: NCST, SMI, MSN, CHLN Higher; TONE, RHIE, CLWR, STV Lower
- Notable ETF Movers: XLF, XHM, AGQ, SGG Up; IEO, EWU, TBT Down
- Notable Analyst Rating Changes 11/11: SMI, TOL, SFD, MCHP Upgraded; PCLN, SNV, RHIE, ADBE, SIGM, HUM Downgraded
- Notable Mergers and Acquisitions of the Day 11/11: BIN/WSII, NCST/SNN, SYK/SURG, LOGI/LifeSize
- Morning Movers 11/11: NCST, SMI, MSN, CHLN, NLST, REGN Higher; TGIC, STS, CLWR, STV, MHR, MBLX Lower
StreetInsider.com Notable Analyst Rating Changes:
UPGRADES:
Bear Stearns upgrades Vodafone (NYSE: VOD) from Peer Perform to Outperform.
Deutsche Bank upgrades China Mobile (NYSE: CHL) to Buy and raises its price target 35% to HK$143.20.
Citi upgrades AstraZeneca (NYSE: AZN) from Hold to Buy. Price target $46.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
Goldman Sachs downgrades UST Inc. (NYSE: UST) from Buy to Neutral.
JP Morgan downgrades Crocs (Nasdaq: CROX) from Overweight to Neutral.
UBS downgrades Dick's Sporting Goods (NYSE: DKS) from Buy to Neutral.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
Morgan Keegan resumes coverage on XTO Energy (NYSE: XTO) with an Outperform.
Goldman Sachs initiates coverage on Philip Morris International (NYSE: PM) with a Buy rating and $60 price target.
UBS initiates coverage on Enbridge (NYSE: ENB) with a Buy rating.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Related Categories
Special ReportsStocks Mentioned
-0.31
+0.93Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
